Multiple REMS Programs May Create Risks For Pharmacists
Executive Summary
Pharmacists would of course like to get reimbursed for assisting with the administration of the Risk Evaluation and Mitigation Strategies for the products they dispense. But beyond that, they would like to see REMS standardized so that they can be used efficiently
You may also be interested in...
APhA Sells Location, Location, Location In Health Care Reform Debate
After President Obama's address to Congress, the focal point of the health care reform debate seems to be shifting to the Senate Finance Committee's pending markup of its legislation, but the American Pharmacists Association is continuing to focus on its pre-recess achievements
APhA Sells Location, Location, Location In Health Care Reform Debate
After President Obama's address to Congress, the focal point of the health care reform debate seems to be shifting to the Senate Finance Committee's pending markup of its legislation, but the American Pharmacists Association is continuing to focus on its pre-recess achievements
REMS For Opioids Still Has A Long Road Ahead; Advisory Committee Is Likely
A finalized Risk Evaluation and Mitigation Strategy for opioids is a long way off - possibly more than a year - and FDA expects additional stakeholder and industry meetings, as well as a multidisciplinary advisory committee to take place before a program is set in stone